The goal of our research is to develop novel immunotherapeutic approaches to treat refractory human diseases (e.g. cancer, neurodegenerative diseases, and autoimmune diseases). In doing so, we design, synthesize, and test diverse therapeutic modalities including novel antibody scaffolds, engineered immune cells, and genetically modified virus, as well as their combinations.